Patients with concomitant heart failure and COPD are underprescribed beta-blockers, representing a significant gap in guideline-directed medical therapy.
Answers are grounded in this paper and cite their sources.
May signal underuse of β-blockers in COPD with HF; leaves open whether closing the gap improves outcomes.
These data indicate a substantial unmet need for patients with COPD who should be prescribed β-blockers more often for concomitant HF.
No takes yet. Share an insight, caveat, or question.
Lipworth et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: